Invitation to a conference call
EntrestoTM US approval
July 08, 2015 - 07:30 am CEST
We are pleased to invite you to a conference call to discuss
EntrestoTM (LCZ696) US approval.
The call will be hosted by David Epstein, Novartis Pharmaceuticals division head, and will take place on July 08, 2015, at 07:30 am CEST
| Date : | Wednesday, July 08, 2015 | |
| Time : | 07:30 am 06:30 am 01:30 am | Switzerland UK New York |
| Dial-in : | +41 43 547 8000 +44 20 3427 1915 +1 646 254 3388 +33 1 76 77 22 24 +49 69 2222 10627 | Local - Zurich, Switzerland Local - London, United Kingdom Local - New York, USA Local - Paris, France Local - Frankfurt, Germany |
| Participant Passcode : | 6569803 | |
| The slide deck is attached and available on the Web A replay will be available on-line as soon as possible after the call. https://www.novartis.com/investors/event-calendar | ||
Novartis Global Investor Relations / General phone: +41 61 324 79 44
Samir Shah / Global Head Investor Relations +41 61 324 79 44
| Basel Office | North America Office | ||
| Pierre-Michel Bringer Thomas Hungerbuehler Isabella Zinck | +41 61 324 10 65 +41 61 324 84 25 +41 61 324 71 88 | Richard Pulik Sloan Pavsner | +1 212 830 24 48 +1 212 830 24 17 |
